Network·Venture Capital
📍 NEW YORK, NY
SEC CRD #801-117168
Commodore Capital invests in innovative biopharmaceutical companies focused on genetic medicines and cellular therapies to bring safe and effective new medicines to patients.
AMEYA BAPAT
CHIEF COMPLIANCE OFFICER & GENERAL COUNSEL & COO
📞 (212) 256-8600
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
AUM
$2.4B
Check Size
$444M–$444M
Location
NEW YORK, NY
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.